These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 26791788)

  • 1. Lungtech, a phase II EORTC trial of SBRT for centrally located lung tumours - a clinical physics perspective.
    Lambrecht M; Melidis C; Sonke JJ; Adebahr S; Boellaard R; Verheij M; Guckenberger M; Nestle U; Hurkmans C
    Radiat Oncol; 2016 Jan; 11():7. PubMed ID: 26791788
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Results of a multicentre dosimetry audit using a respiratory phantom within the EORTC LungTech trial.
    Lambrecht ML; Eaton DJ; Sonke JJ; Nestle U; Peulen H; Weber DC; Verheij M; Hurkmans CW
    Radiother Oncol; 2019 Sep; 138():106-113. PubMed ID: 31252291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiotherapy quality assurance of SBRT for patients with centrally located lung tumours within the multicentre phase II EORTC Lungtech trial: Benchmark case results.
    Lambrecht M; Clementel E; Sonke JJ; Nestle U; Adebahr S; Guckenberger M; Andratschke N; Weber DC; Verheij M; Hurkmans CW
    Radiother Oncol; 2019 Mar; 132():63-69. PubMed ID: 30825971
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dosimetric comparison of stereotactic body radiotherapy using 4D CT and multiphase CT images for treatment planning of lung cancer: evaluation of the impact on daily dose coverage.
    Wang L; Hayes S; Paskalev K; Jin L; Buyyounouski MK; Ma CC; Feigenberg S
    Radiother Oncol; 2009 Jun; 91(3):314-24. PubMed ID: 19111362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The relative accuracy of 4D dose accumulation for lung radiotherapy using rigid dose projection versus dose recalculation on every breathing phase.
    Valdes G; Lee C; Tenn S; Lee P; Robinson C; Iwamoto K; Low D; Lamb JM
    Med Phys; 2017 Mar; 44(3):1120-1127. PubMed ID: 28019649
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dosimetric verification in participating institutions in a stereotactic body radiotherapy trial for stage I non-small cell lung cancer: Japan clinical oncology group trial (JCOG0403).
    Nishio T; Kunieda E; Shirato H; Ishikura S; Onishi H; Tateoka K; Hiraoka M; Narita Y; Ikeda M; Goka T
    Phys Med Biol; 2006 Nov; 51(21):5409-17. PubMed ID: 17047260
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Planning benchmark study for SBRT of early stage NSCLC : Results of the DEGRO Working Group Stereotactic Radiotherapy.
    Moustakis C; Blanck O; Ebrahimi Tazehmahalleh F; Ka Heng Chan M; Ernst I; Krieger T; Duma MN; Oechsner M; Ganswindt U; Heinz C; Alheit H; Blank H; Nestle U; Wiehle R; Kornhuber C; Ostheimer C; Petersen C; Pollul G; Baus W; Altenstein G; Beckers E; Jurianz K; Sterzing F; Kretschmer M; Seegenschmiedt H; Maass T; Droege S; Wolf U; Schoeffler J; Haverkamp U; Eich HT; Guckenberger M
    Strahlenther Onkol; 2017 Oct; 193(10):780-790. PubMed ID: 28567503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dosimetric impact of breathing motion in lung stereotactic body radiotherapy treatment using intensity modulated radiotherapy and volumetric modulated arc therapy [corrected].
    Rao M; Wu J; Cao D; Wong T; Mehta V; Shepard D; Ye J
    Int J Radiat Oncol Biol Phys; 2012 Jun; 83(2):e251-6. PubMed ID: 22365622
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 4D VMAT, gated VMAT, and 3D VMAT for stereotactic body radiation therapy in lung.
    Chin E; Loewen SK; Nichol A; Otto K
    Phys Med Biol; 2013 Feb; 58(4):749-70. PubMed ID: 23324560
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quality assurance of 4D-CT scan techniques in multicenter phase III trial of surgery versus stereotactic radiotherapy (radiosurgery or surgery for operable early stage (stage 1A) non-small-cell lung cancer [ROSEL] study).
    Hurkmans CW; van Lieshout M; Schuring D; van Heumen MJ; Cuijpers JP; Lagerwaard FJ; Widder J; van der Heide UA; Senan S
    Int J Radiat Oncol Biol Phys; 2011 Jul; 80(3):918-27. PubMed ID: 20950961
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Global harmonization of quality assurance naming conventions in radiation therapy clinical trials.
    Melidis C; Bosch WR; Izewska J; Fidarova E; Zubizarreta E; Ulin K; Ishikura S; Followill D; Galvin J; Haworth A; Besuijen D; Clark CH; Miles E; Aird E; Weber DC; Hurkmans CW; Verellen D
    Int J Radiat Oncol Biol Phys; 2014 Dec; 90(5):1242-9. PubMed ID: 25539374
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LungTech, an EORTC Phase II trial of stereotactic body radiotherapy for centrally located lung tumours: a clinical perspective.
    Adebahr S; Collette S; Shash E; Lambrecht M; Le Pechoux C; Faivre-Finn C; De Ruysscher D; Peulen H; Belderbos J; Dziadziuszko R; Fink C; Guckenberger M; Hurkmans C; Nestle U
    Br J Radiol; 2015 Jul; 88(1051):20150036. PubMed ID: 25873481
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthetic 4D-CT of the thorax for treatment plan adaptation on MR-guided radiotherapy systems.
    Freedman JN; Bainbridge HE; Nill S; Collins DJ; Kachelrieß M; Leach MO; McDonald F; Oelfke U; Wetscherek A
    Phys Med Biol; 2019 May; 64(11):115005. PubMed ID: 30844775
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dosimetric Consequences of 3D Versus 4D PET/CT for Target Delineation of Lung Stereotactic Radiotherapy.
    Siva S; Chesson B; Callahan JW; Hardcastle N; Crawford L; Antippa P; Wright G; MacManus MP; Hicks RJ; Kron T; Ball DL
    J Thorac Oncol; 2015 Jul; 10(7):1112-5. PubMed ID: 26134229
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Verification of planning target volume settings in volumetric modulated arc therapy for stereotactic body radiation therapy by using in-treatment 4-dimensional cone beam computed tomography.
    Takahashi W; Yamashita H; Kida S; Masutani Y; Sakumi A; Ohtomo K; Nakagawa K; Haga A
    Int J Radiat Oncol Biol Phys; 2013 Jul; 86(3):426-31. PubMed ID: 23562767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Additional PET/CT in week 5-6 of radiotherapy for patients with stage III non-small cell lung cancer as a means of dose escalation planning?
    Gillham C; Zips D; Pönisch F; Evers C; Enghardt W; Abolmaali N; Zöphel K; Appold S; Hölscher T; Steinbach J; Kotzerke J; Herrmann T; Baumann M
    Radiother Oncol; 2008 Sep; 88(3):335-41. PubMed ID: 18514339
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stereotactic Body Radiotherapy for Centrally Located Inoperable Early-Stage NSCLC: EORTC 22113-08113 LungTech Phase II Trial Results.
    Levy A; Adebahr S; Hurkmans C; Ahmed M; Ahmad S; Guckenberger M; Geets X; Lievens Y; Lambrecht M; Pourel N; Lewitzki V; Konopa K; Franks K; Dziadziuszko R; McDonald F; Fortpied C; Clementel E; Fournier B; Rizzo S; Fink C; Riesterer O; Peulen H; Andratschke N; McWilliam A; Gkika E; Schimek-Jasch T; Grosu AL; Le Pechoux C; Faivre-Finn C; Nestle U
    J Thorac Oncol; 2024 Sep; 19(9):1297-1309. PubMed ID: 38788924
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigation of respiration induced intra- and inter-fractional tumour motion using a standard Cone Beam CT.
    Gottlieb KL; Hansen CR; Hansen O; Westberg J; Brink C
    Acta Oncol; 2010 Oct; 49(7):1192-8. PubMed ID: 20831512
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dose calculations accounting for breathing motion in stereotactic lung radiotherapy based on 4D-CT and the internal target volume.
    Admiraal MA; Schuring D; Hurkmans CW
    Radiother Oncol; 2008 Jan; 86(1):55-60. PubMed ID: 18082905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The feasibility of evaluating radiation dose to the heart by integrating kilovoltage-cone beam computed tomography in stereotactic body radiotherapy of early non-small-cell lung cancer patients.
    Liu C; Gong G; Guo C; Liu T; Lu J; Zhao H; Dong W; Yin Y
    Radiat Oncol; 2013 Dec; 8():295. PubMed ID: 24369788
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.